Article Text

PDF

Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin.
  1. I Sabroe,
  2. J McHale,
  3. D R Tait,
  4. W A Lynn,
  5. K N Ward,
  6. S Shaunak
  1. Department of Infectious Diseases and Bacteriology, Royal Postgraduate Medical School, London, UK.

    Abstract

    A 67 year old woman developed a severe adenoviral pneumonitis whilst receiving immunosuppressive therapy. She showed clinical and radiological evidence of a response to treatment with nebulised and intravenous ribavirin and intravenous pooled normal human immunoglobulin. To our knowledge this is the first time that such a therapeutic approach has been used in the treatment of a condition which normally carries a very high mortality.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.